Patents by Inventor Peter Madsen

Peter Madsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8588129
    Abstract: A system for communicating with one or more satellites over two frequencies, where information identifying the second frequency is transmitted over the first frequency. Usually, the most important data is transmitted over the first frequency at which communication usually is the most stable, whereas communication over the second frequency usually has a higher bandwidth.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: November 19, 2013
    Assignee: Thrane & Thrane A/S
    Inventors: Lars Peter Madsen, Kristjan Sonne Norgaard, Anders Christian Christensen
  • Patent number: 8476228
    Abstract: The present invention relates to insulin derivatives having a side chain attached either to the ?-amino group of the N-terminal amino acid residue of the B chain or to the ?-amino group of a Lys residue present in the B chain of the parent insulin via an amide bond which side chain comprises at least one aromatic group; at least one free carboxylic acid group or a group which is negatively charged at neutral pH, a fatty acid moiety with 4 to 22 carbon atoms in the carbon chain; and possible linkers which link the individual components in the side chain together via amide bonds.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: July 2, 2013
    Assignee: Novo Nordisk A/S
    Inventors: János Tibor Kodra, Patrick William Garibay, Thomas Hoeg-Jensen, Ib Jonassen, Peter Madsen, Tina Møller Tagmose
  • Publication number: 20130157938
    Abstract: The present invention is related to insulin derivatives containing additional disulfide bonds and methods of making such.
    Type: Application
    Filed: June 21, 2011
    Publication date: June 20, 2013
    Applicant: NOVO NORDISK A/S
    Inventors: Peter Madsen, Frantisek Hubalek, Thomas Boerglum Kjeldsen, Svend Ludvigsen
  • Patent number: 8438761
    Abstract: A method for operating two spreader clamps for receiving and holding in pairs pieces of cloth and for spreading out the pieces of cloth before they are delivered to a conveyor, that includes selecting whether the two spreader clamps first spread a piece of cloth about one of two outer centerlines of the conveyor for small-sized pieces of cloth or about a first centerline for large-sized pieces of cloth, feeding a piece of cloth to the spreader clamps, moving the two spreader clamps so as to be situated in relation to the centerline selected, initiating movement of the spreader clamps to either side of the centerline selected to spread the piece of cloth and ascertaining during the spreading about the centerline selected if the piece of cloth is a large-sized piece or a small-sized piece, wherein if an outer centerline is selected and it is ascertained that a piece is a large-sized piece of cloth, moving the two spreader clamps so that the piece of cloth is spread about the first centerline and if the first ce
    Type: Grant
    Filed: May 23, 2008
    Date of Patent: May 14, 2013
    Assignee: Jensen Denmark A/S
    Inventors: Steen Nielsen, Kim Cordua, Henrik Andersen, Niels Peter Madsen
  • Publication number: 20120307720
    Abstract: A system for communicating with one or more satellites over two frequencies, where information identifying the second frequency is transmitted over the first frequency. Usually, the most important data is transmitted over the first frequency at which communication usually is the most stable, whereas communication over the second frequency usually has a higher bandwidth.
    Type: Application
    Filed: December 29, 2010
    Publication date: December 6, 2012
    Applicant: THRANE & THRANE A/S
    Inventors: Lars Peter Madsen, Kristjan Sonne Norgaard, Anders Christian Christensen
  • Publication number: 20120245085
    Abstract: If albumin is added to a pharmaceutical formulation containing acylated insulin described in WO 2009/022005 and WO 2009/022013, the acylated insulin can be kept in solution after subcutaneous injection.
    Type: Application
    Filed: November 1, 2010
    Publication date: September 27, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Helle Naver, Svend Havelund, Peter Madsen
  • Publication number: 20120208749
    Abstract: The present invention is related to insulin derivatives having a side chain attached either to the ?-amino group of the N-terminal amino acid residue of B chain or to an ?-amino group of a Lys residue present in the B chain of the parent insulin molecule via an amide bond which side chain comprises one or more residues of ethyleneglycol, propyleneglycol and/or butyleneglycol containing independently at each termini a group selected from —NH2 and —COOH; a fatty diacid moiety with 4 to 22 carbon atoms, at least one free carboxylic acid group or a group which is negatively charged at neutral pH; and possible linkers which link the individual components in the side chain together via amide or ether bonds, said linkers optionally comprising a free carboxylic acid group.
    Type: Application
    Filed: April 9, 2012
    Publication date: August 16, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Patrick William Garibay, Thomas Hoeg-Jensen, Ib Jonassen, Svend Havelund, Peter Madsen, Palle Jakobsen
  • Publication number: 20120071402
    Abstract: Novel PEGylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H. The PEGylation is at B29K.
    Type: Application
    Filed: November 29, 2011
    Publication date: March 22, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Peter Madsen, Thomas Hoeg-Jensen, Thomas Børglum Kjeldsen, Tina Møller Tagmose
  • Publication number: 20120035104
    Abstract: The present invention relates to insulin derivatives having a side chain attached either to the ?-amino group of the N-terminal amino acid residue of the B chain or to the ?-amino group of a Lys residue present in the B chain of the parent insulin via an amide bond which side chain comprises at least one aromatic group; at least one free carboxylic acid group or a group which is negatively charged at neutral pH, a fatty acid moiety with 4 to 22 carbon atoms in the carbon chain; and possible linkers which link the individual components in the side chain together via amide bonds.
    Type: Application
    Filed: October 14, 2011
    Publication date: February 9, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Janos Tibor Kodra, Patrick William Garibay, Thomas Hoeg-Jensen, Ib Jonassen, Peter Madsen, Tina Moeller Tagmose
  • Publication number: 20110319591
    Abstract: PEGylated, extended insulins are insulins which, compared with human insulin, has one or more extensions extended from the A1, B1, A21 and/or B30 position(s), said extension(s) consist(s) of amino acid residue(s) and wherein a PEG moiety, via a linker, is attached to one or more of the amino acid residues in the extension(s). PEG is polyethyleneglycol. Such PEGylated, extended insulins have higher bioavailability and a longer time-action profile than regular insulin and are in particular suited for pulmonary administration and can, conveniently, be used to treat diabetes.
    Type: Application
    Filed: September 2, 2011
    Publication date: December 29, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Peter Madsen, Thomas Børglum Kjeldsen, Tina Møller Tagmose, Palle Jackobsen
  • Publication number: 20110213131
    Abstract: A method has for selectively acylating an amino group in a peptide or protein which has two or more reactive nucleophilic functional groups is described.
    Type: Application
    Filed: September 11, 2009
    Publication date: September 1, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Caspar Christensen, Rune Severinsen, Anders Klarskov Petersen, Steffen Kidal, Claus U. Jessen, Peter Madsen, Henrik Valore, Tina Møller Tagmose, Jan Lindy Sørensen
  • Publication number: 20110158780
    Abstract: The invention concerns a method and corresponding apparatus of transferring a piece of cloth (3) from a pair of spreader clamps (4,5) to a conveyor (1) via a transverse boom, where the piece of cloth is first suspended and straightened between the spreader clamps, then delivered to the transverse boom (8,9), and subsequently delivered from the transverse boom to the conveyor. Apart from that, a straightening of the fore edge of the piece of cloth is performed, seen in the direction of conveyance of the conveyor, after its delivery from the clamps to the transverse boom has been initiated, but before it is delivered to the conveyor.
    Type: Application
    Filed: December 16, 2008
    Publication date: June 30, 2011
    Inventors: Steen Nielsen, Henrik Munch Jensen, Niels Peter Madsen
  • Publication number: 20110105720
    Abstract: Novel acylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H.
    Type: Application
    Filed: March 13, 2009
    Publication date: May 5, 2011
    Inventors: Peter Madsen, Thomas Børglum Kjeldsen, Thomas Hoeg-Jensen, Palle Jakobsen, Tina Møller Tagmose, Tine Glendorf, Jånos Tibor Kodra, Patrick William Garibay, Jacob Sten Petersen
  • Publication number: 20110098440
    Abstract: An acylated insulin analogue wherein the insulin analogue comprises a lysine residue connected C-terminally to the A21 amino acid residue or a peptide residue of up to 4 amino acid residues comprising a lysine residue which peptide residue is connected C-terminally to the A21 amino acid residue, characterized in that an acyl moiety comprising an alkylene glycol moiety is attached to the lysine residue in the A22 position or attached to a lysine residue present in the peptide residue that is attached to the C terminal end of the A21 amino acid residue and wherein there is only one lysine (K, Lys) in the insulin analogue, can conveniently be administered pulmonary.
    Type: Application
    Filed: August 15, 2008
    Publication date: April 28, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Peter Madsen, Kjeldsen Thomas Borglum, Hoeg-Jensen Thomas, Tagmose Tina Moller, Jakobsen Palle, Kodra János Tibor, Garbay Patrick William, Gram Dorte Xenia
  • Publication number: 20110098439
    Abstract: Acylated insulins wherein an acyl moiety is attached to the parent insulin and wherein said acyl moiety comprises repeating units of alkylene glycol containing amino acids and wherein there is only one lysine residue (K & Lys) in the parent insulin have satisfactory properties when administered pulmonary.
    Type: Application
    Filed: August 15, 2008
    Publication date: April 28, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Peter Madsen, Thomas Børglum Kjeldsen, János Tibor Kodra, Dorte Xenia Gram
  • Publication number: 20110039769
    Abstract: Insulin albumin conjugates consisting of an insulin analogue, a bifunctional linker and albumin can efficiently be used to treat diabetic patients.
    Type: Application
    Filed: March 31, 2009
    Publication date: February 17, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Tina Møller Tagmose, Peter Madsen, Thomas Børglum Kjeldsen
  • Patent number: 7879893
    Abstract: The present invention relates to novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer having the formula A-B-C-D-X (III), wherein: A is a chemical group which reversibly binds to a HisB10 Zn2+ sites of an insulin hexamer; B is a linker; C is a fragment consisting of 0 to 5 neutral amino acids; D is a fragment comprising 1 to 20 positively charged groups independently selected from amino or guanidino groups; and X is —OH, —NH2 or a diamino group. The present invention also relates to R-state insulin hexamers comprising such ligands, and aqueous insulin preparations comprising such R-state insulin hexamers.
    Type: Grant
    Filed: September 13, 2002
    Date of Patent: February 1, 2011
    Assignee: Novo Nordisk A/S
    Inventors: Helle Birk Olsen, Niels C. Kaarsholm, Peter Madsen, Soren Ostergaard, Svend Ludvigsen, Palle Jakobsen, Anders Klarskov Petersen, Dorte Bjerre Steensgaard
  • Publication number: 20100242318
    Abstract: In an apparatus at least two spreader clamps (10, 11) that are configured for receiving a piece of cloth from two pairs of conveyor clamps (16, 17) that belong to a charger station (14). Typically, three or more charger stations (14) are provided. The operator of the apparatus first assesses whether a given batch of pieces of cloth predominantly contains small-sized pieces of cloth, of which more can sit next to each other on the conveyor belt (6) of the apparatus, or large-sized pieces of cloth that may take up as much space as the full working width of the apparatus. If the apparatus is set to the batch of pieces of cloth predominantly containing small-sized pieces of cloth, the spreader clamps (10, 11) are operated such that, for each single piece of cloth in the portion, they are operated to first spread the clamps to each their side of a centreline for small-sized pieces of cloth.
    Type: Application
    Filed: May 23, 2008
    Publication date: September 30, 2010
    Inventors: Steen Nielsen, Kim Cordua, Henrik Andersen, Niels Peter Madsen
  • Publication number: 20100227796
    Abstract: The present invention is related to insulin derivatives having a side chain attached either to the ?-amino group of the N-terminal amino acid residue of B chain or to an ?-amino group of a Lys residue present in the B chain of the parent insulin molecule via an amide bond which side chain comprises one or more residues of ethylenglycol, propyleneglycol and/or butyleneglycol containing independently at each termini a group selected from —NH2 and —COOH; a fatty diacid moiety with 4 to 22 carbon atoms, at least one free carboxylic acid group or a group which is negatively charged at neutral pH; and possible linkers which link the individual components in the side chain together via amide or ether bonds, said linkers optionally comprising a free carboxylic acid group.
    Type: Application
    Filed: May 17, 2010
    Publication date: September 9, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Patrick William Garibay, Thomas Hoeg-Jensen, Ib Jonassen, Svend Havelund, Peter Madsen, Palle Jakobsen
  • Publication number: 20100216691
    Abstract: Novel PEGylated insulin analogues exhibiting resistance towards proteases can, effectively, be administered pulmonary or orally. The insulin analogues contain B25H and A14E or A14H. The PEGylation is at B29K.
    Type: Application
    Filed: July 9, 2008
    Publication date: August 26, 2010
    Applicant: Novo Nordisk A/S
    Inventor: Peter Madsen